共 50 条
- [21] An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancerONKOLOGIE, 2007, 30 (07): : 355 - 360Salzberg, MarcRochlitz, ChristophMorant, RudolfThalmann, GeorgePedrazzini, AugustoRoggero, EnricoSchoeneberger, AstridKnuth, AlexanderBorner, Markus
- [22] Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)Desai, JayeshFakih, MarwanPedersen, Katrina SophiaHong, Yong SangSegal, Neil HowardAllen, SimonBailey, LornaLenain, ChristelleLu, DannySayyed, Pakeeza ZahraSchulze, JochenCecchini, Michael
- [23] Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical TrialCANCER CONTROL, 2022, 29Zhao, XianzhiXiao, Yu-TianYang, YueYe, YushengChang, YifanJiang, LingongEftekhar, MdRen, ShanchengZhang, Huojun
- [24] A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC).JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)Pook, David WilliamGeynisman, Daniel M.Carles, JoanDe Braud, Filippo G.Joshua, Anthony M.Perez-Gracia, Jose LuisPerez, Casilda LlacerShin, Sang JoonFang, BrunoBarve, Minal A.Maruzzo, MarcoBracarda, SergioKim, MisoKerloeguen, YannickGallo, Jorge DanielMaund, SophiaHarris, AdamHuang, Kuan-ChiehSutaria, Dhruvitkumar S.Gurney, Howard
- [25] Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation StudyJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3097 - 3103Huinink, Wim W. ten BokkelSufliarsky, JozefSmit, Willem M.Spanik, StanislavWagnerova, MariaHirte, Hal W.Kaye, StanJohri, Anandhi R.Oza, Amit M.
- [26] Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy VolunteersCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 87 - 94Cohen, Fredric
- [27] Efficacy and safety of eribulin in combination with capecitabine in patients with metastatic breast cancer: An open-label, phase II dose-confirmation studyOncology Research and Treatment, 2015, 38 : 253 - 253Savulsky, C.Twelves, C.Anthoney, A.Yin, S.Evans, T. R. J.
- [28] Efficacy and safety of eribulin in combination with capecitabine in patients with metastatic breast cancer: an open-label, phase II dose-confirmation studyCANCER RESEARCH, 2015, 75Twelves, ChrisNasim, Muhammad Y.Anthoney, AlanSavulsky, Claudio I.Yin, ShuxinEvans, T. R. Jeffry
- [29] A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Patients with Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)BLOOD, 2009, 114 (22) : 53 - 53Garcia-Manero, GuillermoGore, Steven D.Skikne, BarryCogle, Christopher R.Ning, YuhongMacBeth, Kyle J.Laille, EricWard, M. Renee
- [30] A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial CarcinomaCANCER MEDICINE, 2025, 14 (07):Pili, RobertoQuinn, David I.Adra, NabilLogan, TheodoreColligan, SeanBurney, Heather N.Hahn, Noah M.